Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Metabolic Associated Fatty Liver Disease Clinical Trials

3 recruiting trials for Metabolic Associated Fatty Liver Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGEarly Phase 1NCT07185932

Efficacy and Safety of Rifaximin in Treating MAFLD

Study Objective: to evaluate the efficacy and safety of rifaximin in the treatment of metabolic-associated fatty liver disease (MAFLD), and investigate the underlying mechanisms...

Sponsor: Shanghai Changzheng HospitalEnrolling: 401 location
RECRUITINGNCT05597709

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

In 2019, the number of patients with diabetes was about 463 million in the world, accounting for 8.3% of the total population, and it is expected to rise to 578 million (9.2%) by...

Sponsor: Wuxi Hisky Medical Technology Co LtdEnrolling: 29001 location
RECRUITINGNCT07122700

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory...

Sponsor: Foundation for the National Institutes of HealthEnrolling: 4004 locations